These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12733850)

  • 21. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
    Weaver TE; Cuellar N
    Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orally administered sodium oxybate for the treatment of narcolepsy.
    Thorpy M
    Curr Neurol Neurosci Rep; 2004 Mar; 4(2):155-6. PubMed ID: 14984688
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav
    Heo YA
    CNS Drugs; 2022 May; 36(5):541-549. PubMed ID: 35357671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
    Lecendreux M; Plazzi G; Dauvilliers Y; Rosen CL; Ruoff C; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
    J Clin Sleep Med; 2022 Sep; 18(9):2217-2227. PubMed ID: 35689598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice.
    Drakatos P; Lykouras D; D'Ancona G; Higgins S; Gildeh N; Macavei R; Rosenzweig I; Steier J; Williams AJ; Muza R; Kent BD; Leschziner G
    Sleep Med; 2017 Jul; 35():80-84. PubMed ID: 28619187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of narcolepsy-cataplexy with nocturnal gamma-hydroxybutyrate.
    Broughton R; Mamelak M
    Can J Neurol Sci; 1979 Feb; 6(1):1-6. PubMed ID: 264152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H; Kotagal S
    Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium oxybate: a review of its use in the management of narcolepsy.
    Robinson DM; Keating GM
    CNS Drugs; 2007; 21(4):337-54. PubMed ID: 17381187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate?
    Abril B; Carlander B; Touchon J; Dauvilliers Y
    Sleep Med; 2007 Mar; 8(2):181-3. PubMed ID: 17275405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
    Scrima L; Hartman PG; Johnson FH; Thomas EE; Hiller FC
    Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
    Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
    Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
    Busardò FP; Jones AW
    Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.